Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00683488 · ClinicalTrials.gov registry record · NA
Integrated Treatment of Marijuana Abuse for HIV+ Youth
A NA study, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- NA
- Development phase
- 46
- Enrollment target
NCT00683488: Completed NA study, sponsored by University of North Carolina, Chapel Hill.
NCT00683488 is a NA study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 46 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00683488, a NA study, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- NA
- Development phase
- 46 participants
- Enrollment target
Study Summary
This is an exploratory study that will adapt and test a combined cognitive behavioral treatment and contingency management intervention for alcohol and/or marijuana abuse for use in HIV-infected adolescents.
Interventions
- BEHAVIORAL Focus Group
- BEHAVIORAL First Intervention Trial
- BEHAVIORAL Intervention Trial 2
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2008-04 |
| Est. Completion | 2011-04 |
| Phase | NA |
What the finished NCT00683488 record still lists
NCT00683488 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 46 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 3 interventions - of which Focus Group is the first listed.
NCT00683488 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00683488 about?
NCT00683488 is a clinical study titled "Integrated Treatment of Marijuana Abuse for HIV+ Youth". This is an exploratory study that will adapt and test a combined cognitive behavioral treatment and contingency management intervention for alcohol and/or marijuana abuse for use in HIV-infected adolescents.
What is the current status of trial NCT00683488?
This trial is currently completed. It is a NA study. The enrollment target is 46 participants. The study started on 2008-04. Estimated completion is 2011-04.
What interventions are being tested in trial NCT00683488?
The interventions under investigation include: Focus Group (BEHAVIORAL), First Intervention Trial (BEHAVIORAL), Intervention Trial 2 (BEHAVIORAL).
Who is sponsoring clinical trial NCT00683488?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00683488's enrollment target sits among peer trials
46 1402nd of 2000 higher than 590 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01890590 · 46 participants · NA
A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma
- NCT03191149 · 46 participants · Phase 2
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
- NCT03510208 · 46 participants · Phase 1
Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery
- NCT04048278 · 46 participants · Early Phase 1
Lidocaine Infusion in Pancreatic Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia